| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3187724 | Annales de Dermatologie et de Vénéréologie | 2011 | 5 Pages |
Abstract
The treatment of primary extended or generalized hyperhidrosis is not currently codified. Our study shows the efficacy of oxybutynin in this indication at a moderate dose, with good safety. The satisfaction index was high, with 80% of patients considering the drug very effective and for 10% considering it moderately effective. To our knowledge, this is the first retrospective study in a large population. A placebo-controlled study could provide the grounds for a therapeutic consensus concerning a drug widely known for many years in the treatment of extensive hyperhidrosis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
H. Maillard, M. Fenot, C. Bara, P. Célérier,